Moreover, and consistent with a previous report indicating that Smc3 expression is a negative prognostic factor in DLBCL (6), we showed that reduction in the four core subunits SMC3, STAG2, SMC1A and RAD21 are all independent adverse risk factors. Here, SMC1A is linked to diffuse large B-cell lymphoma.